S&P 500   3,275.65 (+1.20%)
DOW   27,071.71 (+1.15%)
QQQ   267.83 (+1.39%)
AAPL   109.72 (+2.43%)
MSFT   205.29 (+2.34%)
FB   250.24 (+0.49%)
GOOGL   1,428.30 (+1.34%)
AMZN   3,051.73 (+1.73%)
NVDA   500.83 (+3.27%)
TSLA   396.52 (+4.25%)
BABA   270.87 (-0.76%)
CGC   14.48 (-0.82%)
GE   6.15 (+0.65%)
MU   50.19 (+0.68%)
AMD   76.62 (+2.53%)
T   28.19 (+1.15%)
F   6.74 (+1.51%)
ACB   5.27 (+1.93%)
GILD   62.22 (-1.38%)
NFLX   473.88 (+0.69%)
DIS   123.55 (+0.22%)
BAC   23.72 (+1.98%)
BA   147.89 (-2.18%)
S&P 500   3,275.65 (+1.20%)
DOW   27,071.71 (+1.15%)
QQQ   267.83 (+1.39%)
AAPL   109.72 (+2.43%)
MSFT   205.29 (+2.34%)
FB   250.24 (+0.49%)
GOOGL   1,428.30 (+1.34%)
AMZN   3,051.73 (+1.73%)
NVDA   500.83 (+3.27%)
TSLA   396.52 (+4.25%)
BABA   270.87 (-0.76%)
CGC   14.48 (-0.82%)
GE   6.15 (+0.65%)
MU   50.19 (+0.68%)
AMD   76.62 (+2.53%)
T   28.19 (+1.15%)
F   6.74 (+1.51%)
ACB   5.27 (+1.93%)
GILD   62.22 (-1.38%)
NFLX   473.88 (+0.69%)
DIS   123.55 (+0.22%)
BAC   23.72 (+1.98%)
BA   147.89 (-2.18%)
S&P 500   3,275.65 (+1.20%)
DOW   27,071.71 (+1.15%)
QQQ   267.83 (+1.39%)
AAPL   109.72 (+2.43%)
MSFT   205.29 (+2.34%)
FB   250.24 (+0.49%)
GOOGL   1,428.30 (+1.34%)
AMZN   3,051.73 (+1.73%)
NVDA   500.83 (+3.27%)
TSLA   396.52 (+4.25%)
BABA   270.87 (-0.76%)
CGC   14.48 (-0.82%)
GE   6.15 (+0.65%)
MU   50.19 (+0.68%)
AMD   76.62 (+2.53%)
T   28.19 (+1.15%)
F   6.74 (+1.51%)
ACB   5.27 (+1.93%)
GILD   62.22 (-1.38%)
NFLX   473.88 (+0.69%)
DIS   123.55 (+0.22%)
BAC   23.72 (+1.98%)
BA   147.89 (-2.18%)
S&P 500   3,275.65 (+1.20%)
DOW   27,071.71 (+1.15%)
QQQ   267.83 (+1.39%)
AAPL   109.72 (+2.43%)
MSFT   205.29 (+2.34%)
FB   250.24 (+0.49%)
GOOGL   1,428.30 (+1.34%)
AMZN   3,051.73 (+1.73%)
NVDA   500.83 (+3.27%)
TSLA   396.52 (+4.25%)
BABA   270.87 (-0.76%)
CGC   14.48 (-0.82%)
GE   6.15 (+0.65%)
MU   50.19 (+0.68%)
AMD   76.62 (+2.53%)
T   28.19 (+1.15%)
F   6.74 (+1.51%)
ACB   5.27 (+1.93%)
GILD   62.22 (-1.38%)
NFLX   473.88 (+0.69%)
DIS   123.55 (+0.22%)
BAC   23.72 (+1.98%)
BA   147.89 (-2.18%)
Log in
ASX:CAN

Cann Group Limited (CAN.AX) Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Cann Group Limited engages in research and development, cultivation and production, manufacturing, clinical evaluation, processing, packaging, and distribution and supply of medicinal cannabis for various diseases and medical conditions in Australia. The company was founded in 2014 and is based in Bundoora, Australia.
Read More

Beat the Market (BTM) Rank™

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 3.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

0.60 out of 5 stars


Industry, Sector and Symbol

Stock Exchange ASX
Industry Drug Manufacturers—Specialty & Generic
Sub-IndustryN/A
SectorMedical
Current SymbolASX:CAN
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.canngrouplimited.com
Phone61 3 9095 7088

Debt

Debt-to-Equity Ratio15.26
Current Ratio1.93
Quick Ratio0.25

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$1.60 million
Price / Sales0.00
Cash FlowN/A
Price / Cash FlowN/A
Book ValueA$0.43 per share
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding SharesN/A
Market CapN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive CAN News and Ratings via Email

Sign-up to receive the latest news and ratings for CAN and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Cann Group Limited (CAN.AX) (ASX:CAN) Frequently Asked Questions

Who are some of Cann Group Limited (CAN.AX)'s key competitors?

Some companies that are related to Cann Group Limited (CAN.AX) include 4Front Ventures (PCLOF), AAC Technologies (ABSCF), Abattis Bioceuticals (ATT), Aft Pharmaceuticals (AFP), AgraFlora Organics International (AGRA), AgraFlora Organics International (AGFAF), Avicanna (PDDPF), Benitec Biopharma (BLT), Biome Grow (BIOIF), Body and Mind (BAMM), Boiron (BOIRF), Cannabis Global (CBGL), CannLabs (CANL), Chardan Healthcare Acquisition (PHGE) and Chemesis International (CSI).
View all competitors.

Who are Cann Group Limited (CAN.AX)'s key executives?

Cann Group Limited (CAN.AX)'s management team includes the following people:
  • Mr. Peter Crock MBA, Chief Exec. Officer
  • Mr. Greg Bullock, Chief Financial Officer
  • Mr. Neil Gripper, Gen. Mang. of Operations
  • Mr. Geoff Aldred, Chief Projects & Information Officer
  • Mr. Shane Duncan, Gen. Mang. of Commercial

What is Cann Group Limited (CAN.AX)'s stock symbol?

Cann Group Limited (CAN.AX) trades on the ASX under the ticker symbol "CAN."

How big of a company is Cann Group Limited (CAN.AX)?

Cann Group Limited (CAN.AX) has a market capitalization of $0.00 and generates $1.60 million in revenue each year.

What is Cann Group Limited (CAN.AX)'s official website?

The official website for Cann Group Limited (CAN.AX) is www.canngrouplimited.com.

How can I contact Cann Group Limited (CAN.AX)?

The company can be reached via phone at 61 3 9095 7088.

This page was last updated on 9/24/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.